Compounds > deoxyglucose
Page last updated: 2024-09-02

deoxyglucose and Angiogenesis, Pathologic

deoxyglucose has been researched along with Angiogenesis, Pathologic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, AN; Chawla, AS; Dwarakanath, BS; Pandey, S; Roy, BG; Saluja, D; Singh, S1
Bhatt, AN; Bhuria, V; Chaudhary, R; Dwarakanath, BS; Kalra, N; Pandey, S; Roy, BG; Saluja, D; Singh, S; Soni, R1
Edatt, L; Kiran, MS; Kumar, SV; Kunhiraman, H; Poyyakkara, A; Raveendran, V; Sudhakaran, P; Thekkeveedu, S1
Amaya, N; Fukuoka, Y; Ikeda, H; Ishida, K; Kaseno, K; Lee, JD; Morishita, T; Tada, H; Uzui, H1
Fukuda, H; Harada, Y; Kubota, K; Ohira, H; Ohuchi, N; Satomi, S1

Other Studies

5 other study(ies) available for deoxyglucose and Angiogenesis, Pathologic

ArticleYear
Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis.
    European journal of cancer (Oxford, England : 1990), 2019, Volume: 123

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Angiogenesis Inhibitors; Animals; Antimetabolites; Carcinoma, Lewis Lung; Cell Proliferation; Cell Survival; Deoxyglucose; Glucose; Glycolysis; Human Umbilical Vein Endothelial Cells; Humans; Lactic Acid; Lung Neoplasms; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Radiation, Ionizing; Vascular Endothelial Growth Factor A

2019
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Animals; Antimetabolites, Antineoplastic; Blood Glucose; Caloric Restriction; Carcinoma, Ehrlich Tumor; CD4-CD8 Ratio; Cell Division; Deoxyglucose; Drug Screening Assays, Antitumor; Female; Glycolysis; Insulin; Matrix Metalloproteinase 9; Mice; Neoplasm Proteins; Neovascularization, Pathologic; Premedication; Random Allocation; Signal Transduction; T-Lymphocytes, Regulatory; Tumor Burden

2015
2-Deoxy Glucose Modulates Expression and Biological Activity of VEGF in a SIRT-1 Dependent Mechanism.
    Journal of cellular biochemistry, 2017, Volume: 118, Issue:2

    Topics: Animals; Chick Embryo; Deoxyglucose; Gene Expression Regulation, Neoplastic; Glycolysis; HeLa Cells; Humans; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Sirtuin 1; Vascular Endothelial Growth Factor A

2017
Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: AC133 Antigen; Aged; Antigens, CD34; Cell Count; Coronary Artery Disease; Deoxyglucose; Diabetes Mellitus, Type 2; Eicosapentaenoic Acid; Endothelium, Vascular; Female; Humans; Hyperglycemia; Male; Middle Aged; Neovascularization, Pathologic; Risk Factors; Stem Cells; Vascular Endothelial Growth Factor Receptor-2

2016
Comparison of intratumoral distribution of 99mTc-MIBI and deoxyglucose in mouse breast cancer models.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:9

    Topics: Animals; Biological Transport; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Deoxyglucose; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Microcirculation; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; X-Rays

2000